Institutional investors purchased a net $97.2 thousand shares of CVM during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 7.03% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 340.00 shares of CEL-SCI Corp